Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDs

NCT04840550 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

390

Enrollment

INDUSTRY

Sponsor class

Conditions

Preventive Peptic Ulcer

Interventions

DRUG: Lansoprazole 15 mg
DRUG: Tegoprazan 25 mg

Sponsor

HK inno.N Corporation